Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Swiss Cardiac Amyloidosis REgistry (Swiss-CARE)

NCT04776824 is registered in ClinicalTrials.gov with Insel Gruppe AG, University Hospital Bern as lead sponsor.

NCT NCT04776824
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04776824 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Swiss Cardiac Amyloidosis REgistry (Swiss-CARE)
Lead sponsor
Insel Gruppe AG, University Hospital Bern
Phase
Observational
Overall status
Recruiting
Start date
February 22, 2001
Completion date
May 1, 2031
Enrollment
300 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

amyloid cardiomyopathy